Finance Home - My Yahoo - Yahoo! - Help

Monday, November 9, 2009, 9:23PM ET - U.S. Markets Closed. Dow  2.03% Nasdaq  1.97%

Protalix BioTherapeutics, Inc. (PLX)

At 4:00PM ET: 12.14   0.42 (3.58%)

MORE ON PLX

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Today, Mon, Nov 9, 2009 • PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Mon 4:31pm) Tue, Nov 3, 2009 • Nice Quarter, Teva. What Will You Buy Next? at Motley Fool (Tue, Nov 3) Mon, Nov 2, 2009 • UPDATE - Deals of the day -- mergers and acquisitions at Reuters (Mon, Nov 2) • Pfizer eyes deal with Israel's Protalix-newspaper at Reuters (Mon, Nov 2) Thu, Oct 29, 2009 • Protalix BioTherapeutics to Present at the Oppenheimer 20th Annual Healthcare Conference Business Wire (Thu, Oct 29) Mon, Oct 26, 2009 • Biotech Stocks: Pharma stocks turn lower; BioCryst, Vivus gain at MarketWatch (Mon, Oct 26) • Biotech Stocks: Drug stocks edge up; BioCryst soars on flu news at MarketWatch (Mon, Oct 26) Thu, Oct 22, 2009 • The Gift That Keeps on Giving at Motley Fool (Thu, Oct 22) Wed, Oct 21, 2009 • Genzyme Misses & Slashes Zacks.com (Wed, Oct 21) Thu, Oct 15, 2009 • Protalix says Gaucher drug met goals in trial AP (Thu, Oct 15) • UPDATE - Protalix drug success puts new pressure on Genzyme at Reuters (Thu, Oct 15) • CORRECTING and REPLACING Protalix BioTherapeutics Announces Positive Top-line Results from its Phase III Clinical Trial of UPLYSO for the Treatment of Gaucher Disease Business Wire (Thu, Oct 15) • Protalix reports positive Phase III trial results at MarketWatch (Thu, Oct 15) • PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online (Thu, Oct 15) Wed, Oct 14, 2009 • [$$] Production Snafus Expose Genzyme to Rivals at The Wall Street Journal Online (Wed, Oct 14) Thu, Sep 24, 2009 • PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online (Thu, Sep 24) • Genzyme Struggles to Restore Order Zacks.com (Thu, Sep 24) • Sell Genzyme Near Term Due to Challenges with Manufacturing Biologics at Seeking Alpha (Thu, Sep 24) Tue, Sep 22, 2009 • Coverage initiated on Protalix BioTherapeutics by Canaccord Adams Briefing.com (Tue, Sep 22) • Protalix Reports Preclinical Data on Anti-TNF Follow-on Biologic Arthritis Drug Business Wire (Tue, Sep 22) Older Headlines - Download Recent Headlines View headlines from: Tue, Sep 22, 2009Tue, Sep 15, 2009Tue, Sep 8, 2009Tue, Sep 1, 2009Tue, Aug 25, 2009Tue, Aug 18, 2009Tue, Aug 11, 2009Tue, Aug 4, 2009Tue, Jul 28, 2009Tue, Jul 21, 2009 Add PLX News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage